Last reviewed · How we verify
Betamethasone dipropionate aerosol spray
Betamethasone dipropionate aerosol spray is a topical corticosteroid that reduces inflammation and suppresses the immune system.
Betamethasone dipropionate aerosol spray is a topical corticosteroid that reduces inflammation and suppresses the immune system. Used for Severe skin conditions such as psoriasis, atopic dermatitis, and seborrheic dermatitis.
At a glance
| Generic name | Betamethasone dipropionate aerosol spray |
|---|---|
| Sponsor | LEO Pharma |
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
It works by inhibiting the production of pro-inflammatory cytokines and mediators, leading to a decrease in inflammation and immune response. This is achieved through the binding of betamethasone to glucocorticoid receptors, which then modulate gene expression and protein synthesis. As a result, betamethasone dipropionate aerosol spray is effective in treating various skin conditions characterized by inflammation and immune dysregulation.
Approved indications
- Severe skin conditions such as psoriasis, atopic dermatitis, and seborrheic dermatitis
Common side effects
- Skin atrophy
- Hypersensitivity reactions
Key clinical trials
- A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) (PHASE2)
- Efficacy and Tolerability of Enstilar® in Daily Practice
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Betamethasone dipropionate aerosol spray CI brief — competitive landscape report
- Betamethasone dipropionate aerosol spray updates RSS · CI watch RSS
- LEO Pharma portfolio CI